Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / ENDP - Endo International: Loses Vasostrict Trial


ENDP - Endo International: Loses Vasostrict Trial

  • Judge rules Eagle Pharmaceuticals' version of the drug does not infringe on two patents held by Par Pharmaceuticals, the unit that produces vasostrict.
  • Expect Eagle to start producing and marketing a generic form of vasostrict to treat low blood pressure in the next few months.
  • Approximately 30% of Endo Pharmaceuticals' revenue and EBITDA will take a hit.
  • The loss likely wipes out any equity value for Endo and impairs unsecured bonds.

For further details see:

Endo International: Loses Vasostrict Trial
Stock Information

Company Name: Endo International plc
Stock Symbol: ENDP
Market: NASDAQ
Website: endo.com

Menu

ENDP ENDP Quote ENDP Short ENDP News ENDP Articles ENDP Message Board
Get ENDP Alerts

News, Short Squeeze, Breakout and More Instantly...